Pharmacokinetics, Relative Bioavailability and Safety of INL-001 Compared to Marcaine After Open Hernioplasty
Status:
Completed
Trial end date:
2017-08-15
Target enrollment:
Participant gender:
Summary
This is a multicenter randomized, single-blind, controlled study. The primary objectives of
this study are to obtain the pharmacokinetic profile and the relative bioavailability of the
INL-001 matrix during and after open hernioplasty compared to Marcaine™ 0.25% infiltration.